We are live on
!
Find out more
GC
Gratus Capital Portfolio holdings
AUM
$2.5B
1-Year Est. Return
32.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.1%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$680M
AUM Growth
+$224M
(+49%)
Cap. Flow
+$222M
Cap. Flow
% of AUM
32.67%
Top 10 Holdings %
Top 10 Hldgs %
44.16%
Holding
182
New
111
Increased
38
Reduced
20
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$8.08M |
| 2 |
Danaher
DHR
|
+$7.52M |
| 3 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$6.44M |
| 4 |
Graco
GGG
|
+$6.38M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$6.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.37M |
| 2 |
Medtronic
MDT
|
+$2.22M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.08M |
| 4 |
DuPont de Nemours
DD
|
+$2.06M |
| 5 |
Invesco Large Cap Value ETF
PWV
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 34.55% |
| 2 | Financials | 10.83% |
| 3 | Healthcare | 10.25% |
| 4 | Industrials | 9.41% |
| 5 | Technology | 7.51% |
Similar funds
LFDLE
CDH
AT
BPCA
HIG
H
PRIG
PO
Gratus Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Gratus Capital held 182 positions worth $680M, up 49% from $456M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Gratus Capital deployed $222M of net new capital in Q2 2016, opening 111 new positions and adding to 38 existing holdings. Its largest new stake was Valspar: 75,300 shares worth $8.13M.
By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $2.22M trimmed.
- Gratus Capital's largest Q2 2016 buy was Valspar: 75,300 shares worth $8.13M.
- Gratus Capital added most to Berkshire Hathaway Class B in Q2 2016, an estimated $6.38M increase.
- Gratus Capital's biggest Q2 2016 reduction was Medtronic, cutting an estimated $2.22M.
- Gratus Capital fully exited AbbVie in Q2 2016, selling an estimated $6.37M.
- Gratus Capital's ten largest holdings make up 44% of its $680M portfolio in Q2 2016.
- Gratus Capital opened 111 new positions and closed 5 in Q2 2016.
- Gratus Capital's portfolio value rose 49% quarter-over-quarter to $680M.
Based on Gratus Capital's 13F filing for Q2 2016, filed 3 Aug 2016.